Jonathan David Eisenberg, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplasms, Radiation-Induced | 9 | 2015 | 547 | 1.090 |
Why?
|
Radiation Dosage | 7 | 2015 | 1928 | 1.010 |
Why?
|
Life Expectancy | 5 | 2015 | 1184 | 0.560 |
Why?
|
Tomography, X-Ray Computed | 11 | 2017 | 20129 | 0.540 |
Why?
|
Decision Making | 5 | 2015 | 3887 | 0.470 |
Why?
|
Radiography, Abdominal | 1 | 2017 | 537 | 0.450 |
Why?
|
Abdominal Pain | 2 | 2017 | 1063 | 0.450 |
Why?
|
Medical History Taking | 1 | 2012 | 783 | 0.320 |
Why?
|
Benchmarking | 1 | 2014 | 1042 | 0.300 |
Why?
|
Radiometry | 1 | 2012 | 800 | 0.290 |
Why?
|
Surgery, Computer-Assisted | 1 | 2015 | 1018 | 0.280 |
Why?
|
Radiation Injuries | 1 | 2014 | 1180 | 0.280 |
Why?
|
Patient-Centered Care | 1 | 2014 | 1439 | 0.230 |
Why?
|
Radiography | 2 | 2014 | 7023 | 0.230 |
Why?
|
Clinical Competence | 2 | 2017 | 4687 | 0.210 |
Why?
|
Catheter Ablation | 1 | 2015 | 2758 | 0.200 |
Why?
|
Carcinoma, Renal Cell | 1 | 2015 | 3143 | 0.170 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4262 | 0.160 |
Why?
|
Renal Artery Obstruction | 2 | 2009 | 248 | 0.160 |
Why?
|
Risk Assessment | 8 | 2015 | 23338 | 0.130 |
Why?
|
Angioplasty, Balloon | 2 | 2009 | 653 | 0.130 |
Why?
|
Diagnostic Imaging | 3 | 2015 | 3507 | 0.130 |
Why?
|
Abnormalities, Radiation-Induced | 1 | 2014 | 4 | 0.120 |
Why?
|
Kidney Diseases, Cystic | 1 | 2014 | 186 | 0.110 |
Why?
|
Radiation, Ionizing | 1 | 2014 | 258 | 0.110 |
Why?
|
Hypertension, Renovascular | 2 | 2009 | 123 | 0.110 |
Why?
|
Sex Distribution | 1 | 2017 | 2297 | 0.100 |
Why?
|
Age Distribution | 1 | 2017 | 2902 | 0.090 |
Why?
|
Risk Management | 1 | 2014 | 571 | 0.090 |
Why?
|
Models, Statistical | 2 | 2015 | 5102 | 0.090 |
Why?
|
Physicians, Primary Care | 1 | 2016 | 591 | 0.090 |
Why?
|
Sensitivity and Specificity | 5 | 2017 | 14722 | 0.080 |
Why?
|
Appendicitis | 1 | 2014 | 645 | 0.080 |
Why?
|
Survival Analysis | 3 | 2015 | 10252 | 0.080 |
Why?
|
Stents | 2 | 2009 | 3280 | 0.070 |
Why?
|
Hodgkin Disease | 1 | 2015 | 1415 | 0.070 |
Why?
|
Pneumonia | 1 | 2019 | 2133 | 0.070 |
Why?
|
Models, Economic | 1 | 2011 | 713 | 0.070 |
Why?
|
Testicular Neoplasms | 1 | 2012 | 804 | 0.070 |
Why?
|
Drug-Eluting Stents | 2 | 2009 | 753 | 0.070 |
Why?
|
Incidental Findings | 1 | 2011 | 689 | 0.070 |
Why?
|
Population Surveillance | 2 | 2015 | 2616 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2012 | 1265 | 0.070 |
Why?
|
Linear Models | 2 | 2013 | 5952 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3114 | 0.060 |
Why?
|
Coronary Vessels | 2 | 2009 | 3107 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2012 | 1206 | 0.060 |
Why?
|
Cardiovascular Agents | 1 | 2009 | 850 | 0.060 |
Why?
|
Prevalence | 2 | 2017 | 15226 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2012 | 5391 | 0.050 |
Why?
|
Male | 16 | 2019 | 350118 | 0.050 |
Why?
|
Myocardial Infarction | 3 | 2019 | 11727 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2012 | 1956 | 0.050 |
Why?
|
Sirolimus | 1 | 2009 | 1564 | 0.050 |
Why?
|
Physician-Patient Relations | 1 | 2015 | 3229 | 0.050 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2009 | 1873 | 0.050 |
Why?
|
Middle Aged | 12 | 2017 | 213383 | 0.050 |
Why?
|
Aged | 11 | 2016 | 163280 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2017 | 19905 | 0.050 |
Why?
|
Female | 16 | 2019 | 380194 | 0.050 |
Why?
|
Communication | 1 | 2015 | 3749 | 0.050 |
Why?
|
Humans | 22 | 2019 | 744343 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2012 | 3474 | 0.050 |
Why?
|
Mammography | 1 | 2012 | 2476 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2016 | 57776 | 0.040 |
Why?
|
Emergency Service, Hospital | 2 | 2016 | 7659 | 0.040 |
Why?
|
Ultrasonography, Doppler, Duplex | 2 | 2009 | 205 | 0.040 |
Why?
|
Registries | 1 | 2012 | 8089 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2014 | 35421 | 0.030 |
Why?
|
Comorbidity | 3 | 2015 | 10388 | 0.030 |
Why?
|
Coronary Thrombosis | 1 | 1999 | 495 | 0.030 |
Why?
|
Incidence | 4 | 2015 | 20947 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 10900 | 0.030 |
Why?
|
Angina Pectoris | 1 | 1999 | 977 | 0.030 |
Why?
|
Young Adult | 3 | 2016 | 56430 | 0.030 |
Why?
|
Risk Factors | 3 | 2017 | 72290 | 0.030 |
Why?
|
United States | 3 | 2017 | 69872 | 0.030 |
Why?
|
Adult | 8 | 2016 | 214055 | 0.030 |
Why?
|
Sentinel Surveillance | 1 | 2014 | 281 | 0.030 |
Why?
|
Deoxyribonuclease I | 1 | 1993 | 229 | 0.030 |
Why?
|
Markov Chains | 1 | 2015 | 969 | 0.030 |
Why?
|
Computer Simulation | 2 | 2015 | 6196 | 0.020 |
Why?
|
Risk | 2 | 2014 | 9687 | 0.020 |
Why?
|
Boston | 2 | 2015 | 9313 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12354 | 0.020 |
Why?
|
Radiation Protection | 1 | 2013 | 419 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2009 | 6487 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2012 | 981 | 0.020 |
Why?
|
Survival Rate | 2 | 2014 | 12788 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2015 | 11031 | 0.020 |
Why?
|
Informed Consent | 1 | 2015 | 995 | 0.020 |
Why?
|
Polytetrafluoroethylene | 1 | 2009 | 233 | 0.020 |
Why?
|
Causality | 1 | 2015 | 1275 | 0.020 |
Why?
|
Recurrence | 2 | 2009 | 8340 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13102 | 0.020 |
Why?
|
Emergency Medicine | 1 | 2016 | 1207 | 0.020 |
Why?
|
Coronary Angiography | 1 | 1999 | 4577 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2012 | 1254 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3396 | 0.020 |
Why?
|
Prospective Studies | 3 | 2016 | 53288 | 0.020 |
Why?
|
Iatrogenic Disease | 1 | 2009 | 547 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 21683 | 0.020 |
Why?
|
Metals | 1 | 2009 | 719 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2924 | 0.020 |
Why?
|
Cystic Fibrosis | 1 | 1993 | 1177 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 20822 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6895 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 7729 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3528 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8324 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2009 | 2110 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2759 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 2009 | 1486 | 0.010 |
Why?
|
Time Factors | 3 | 2009 | 40075 | 0.010 |
Why?
|
Angioscopy | 1 | 1999 | 49 | 0.010 |
Why?
|
Hemodynamics | 1 | 2009 | 4199 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13408 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2012 | 3086 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 2009 | 1972 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18370 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2012 | 9239 | 0.010 |
Why?
|
Kidney | 1 | 2009 | 7186 | 0.010 |
Why?
|
Blood Pressure | 1 | 2009 | 8554 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2009 | 63114 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 13881 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2009 | 77449 | 0.010 |
Why?
|
Aerosols | 1 | 1993 | 625 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1993 | 3508 | 0.000 |
Why?
|
Analysis of Variance | 1 | 1993 | 6365 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1999 | 12959 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 1999 | 15076 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1993 | 12026 | 0.000 |
Why?
|
Lung | 1 | 1993 | 9856 | 0.000 |
Why?
|
Quality of Life | 1 | 1993 | 12804 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1993 | 39050 | 0.000 |
Why?
|
Adolescent | 1 | 1993 | 85781 | 0.000 |
Why?
|